Anti-CDC34 Antibody

CDC34 functions as a ubiquitin-conjugating E2 enzyme that pairs with the SCF complex to tag substrates such as p27 and cyclin E for proteasomal degradation during G1 to S phase progression, and this polyclonal primary antibody from Antibodies.com is raised in rabbit to detect endogenous CDC34 across human, mouse, and rat samples.

Validated for Western blot, immunohistochemistry, and immunofluorescence, the unconjugated reagent supports research use only studies ranging from cell cycle checkpoint analysis to investigations of CDC34 involvement in oncogenesis and proteasome biology.

Supplied in a vial as 100 µl of liquid at 1 mg/ml in PBS with 0.1% Sodium Azide and 50% glycerol, the antibody is aliquoted for stability; store refrigerated, protect from light, and avoid repeated freeze-thaw cycles to preserve binding activity over its shelf life.

Because the polyclonal mixture recognizes multiple epitopes on the target, the reagent tends to deliver a robust signal in immunoblotting and immunostaining protocols where monoclonal antibodies may lose binding to denatured or fixed epitopes.